Product Images Divalproex Sodium

This is a description of a delayed-release tablet of Divalproex Sodium with a dosage strength of 125 mg. The tablet should be protected from light and kept out of reach of children. It is important to swallow the tablets whole and not to crush or chew them. The package insert should be consulted for directions on how to use the medication. The tablet has been repackaged by RemedyRepack Inc. and the original manufacturer is Upsher-Smith Labs, Inc. The lot number and expiration date are not available.*

This is a description of a medication called Delayed-Release in the form of 125 mg tablets. Each box contains 100 tablets. The medication should be protected from light. The active ingredient is Divalproex Sodium. It is a prescription medication and the NDC code is 70518-3796-00. The medication has an expiration date but it is not provided in the text. The lot number is also not provided. The manufacturer is Upsher-Smith Labs, Inc. located in Minneapolis, MN. It is important to keep this medication out of the reach of children. There is a warning to swallow the tablets whole and not crush or chew them. The package insert provides directions for use. The recommended storage temperature is between 20-25°C (88-77°F), with excursions permitted between 15-30°C (59-86°F) as per USP guidelines. The medication has been repackaged by RemedyRepack Inc. located in Indiana, PA.*

This text appears to be a table showing the reduction in CPS rate for different treatments. It includes percentages ranging from 100% to -50%, representing the level of improvement or worsening. The treatments mentioned are "Divalproex sodium" and "Placebo". It also shows the percentage of patients who experienced improvement, no change, or worsening.*